Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1998;29:1810-1815

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cullinane, M.
Right arrow Articles by Markus, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cullinane, M.
Right arrow Articles by Markus, H. S.

(Stroke. 1998;29:1810-1815.)
© 1998 American Heart Association, Inc.


Original Contributions

Asymptomatic Embolization in Subjects With Atrial Fibrillation Not Taking Anticoagulants

A Prospective Study

Marisa Cullinane, BSc; Ray Wainwright, MD; Angie Brown, MD; Mark Monaghan, PhD; Hugh S. Markus, DM

From the Department of Clinical Neurosciences, King's College School of Medicine and Institute of Psychiatry (M.C., H.M.); and Department of Cardiology (R.W., A.B., M.M.), King's College Hospital, London, UK.

Correspondence to Dr Hugh Markus, Department of Clinical Neurosciences, Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, UK. E-mail h.markus{at}iop.bpmf.ac.uk

Background and Purpose—Embolism is believed to be the major cause of stroke in patients with nonvalvular atrial fibrillation (NVAF). The detection of asymptomatic embolic signals (ES) in individuals with NVAF might allow identification of patients at high risk of stroke and monitoring of therapy in individual subjects. We determined the frequency of asymptomatic ES in patients with NVAF who were not taking warfarin.

Methods—Bilateral transcranial Doppler recordings were made for 1 hour from the middle cerebral arteries of 111 successive patients with NVAF taking aspirin alone or no antithrombotic or anticoagulant therapy. Adequate recordings could be made in 86 patients. In 79 subjects, recordings were performed on a second occasion to study temporal variability. Recordings for a single hour were also made in 30 age-matched control subjects.

Results—ES were detected in 13 (15.1%) of NVAF subjects but in no control subjects (P=0.02). ES were detected both in subjects with symptomatic NVAF (4 of 30 [13.1%], P=0.04 versus controls) and asymptomatic NVAF (9 of 56 [16.1%], P=0.02 versus controls). There was no correlation between the presence of ES and smoking status, diabetes, hypertension, aspirin use, aspirin dose, symptomatic status, left atrial size, left ventricular function, or the presence of left atrial thrombus detected on transthoracic echocardiography. Repeating the recording increased the number of patients with ES to 21 (26.6%). On considering the results of both recordings, again there was no association for either recording between the presence of ES and smoking status, diabetes, hypertension, aspirin use, aspirin dose, age, symptomatic status, left atrial size, or left ventricular function. On repeating the recording, in the symptomatic group only 2 patients (8%) changed status, in contrast to 15 (29%) in the asymptomatic group.

Conclusions—ES can be detected in patients with NVAF at a low frequency. Particularly in asymptomatic patients, ES show marked temporal variability. We found no correlation between the presence of previously reported clinical and echocardiographic markers of increased stroke risk and the presence of ES. This association requires further investigation before the clinical utility of this technique in patients with NVAF is decided.


Key Words: atrial fibrillation • cerebrovascular diseases • cerebral embolism • ultrasonics




This article has been cited by other articles:


Home page
StrokeHome page
A. D. Mackinnon, R. Aaslid, and H. S. Markus
Long-Term Ambulatory Monitoring for Cerebral Emboli Using Transcranial Doppler Ultrasound
Stroke, January 1, 2004; 35(1): 73 - 78.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Brucher and D. Russell
Automatic Online Embolus Detection and Artifact Rejection With the First Multifrequency Transcranial Doppler
Stroke, August 1, 2002; 33(8): 1969 - 1974.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Russell and R. Brucher
Online Automatic Discrimination Between Solid and Gaseous Cerebral Microemboli With the First Multifrequency Transcranial Doppler
Stroke, August 1, 2002; 33(8): 1975 - 1980.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Markus
Monitoring Embolism in Real Time
Circulation, August 22, 2000; 102(8): 826 - 828.
[Full Text] [PDF]


Home page
StrokeHome page
M. Cullinane, G. Reid, R. Dittrich, Z. Kaposzta, R. Ackerstaff, V. Babikian, D. W. Droste, D. Grossett, M. Siebler, L. Valton, et al.
Evaluation of New Online Automated Embolic Signal Detection Algorithm, Including Comparison With Panel of International Experts
Stroke, June 1, 2000; 31(6): 1335 - 1341.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Z. G. Nadareishvili, Z. Choudary, C. Joyner, D. Brodie, and J. W. Norris
Cerebral Microembolism in Acute Myocardial Infarction
Stroke, December 1, 1999; 30(12): 2679 - 2682.
[Abstract] [Full Text] [PDF]